ABBV
AbbVie
Health Care
Biotechnology
North Chicago, Illinois
Last filing: Feb 20, 2026 (FY2025)
Balance Sheet 9 Accounts • 5 Years
| Account | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| BS_Assets_AcctsReceivable | $0 | $10.9B | $11.2B | $11.3B | $10.0B |
| BS_Assets_Inventory | $0 | $4.2B | $4.1B | $3.6B | $3.1B |
| BS_Assets_PPE | $0 | $5.1B | $5.0B | $4.9B | $5.1B |
| BS_Assets_Goodwill | $170.0M | $35.0B | $32.3B | $32.2B | $32.4B |
| BS_Assets_IntangibleAssets | $0 | $60.1B | $55.6B | $67.4B | $76.0B |
| BS_Liab_AccruedLiab | $0 | $6.7B | $6.4B | $5.8B | $6.6B |
| BS_Liab_OtherNoncurrent | $0 | $30.1B | $32.3B | $30.7B | $28.7B |
| BS_Equity_CommonStock | $0 | $18.0M | $18.0M | $18.0M | $18.0M |
| BS_Equity_TreasuryStock | $980.0M | $8.2B | $6.5B | $4.6B | $3.1B |